Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus

Neuropharmacology

Volumn 66, Issue , 2013, Pages 133-142

  Copeland, C S ^a   Neale, S A ^a   Salt, T E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endocoid; Metabotropic glutamate receptor; Schizophrenia; Sensory inhibition; Ventrobasal thalamus; Xanthurenic acid

Indexed keywords

KYNURENINE; METABOTROPIC RECEPTOR; XANTHURENIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; EVOKED RESPONSE; IN VIVO STUDY; IONTOPHORESIS; MALE; MOLECULAR DYNAMICS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; SENSORY STIMULATION; SIGNAL TRANSDUCTION; THALAMUS RETICULAR NUCLEUS; THALAMUS VENTRAL NUCLEUS;

ACTION POTENTIALS; ADMINISTRATION, INTRAVENOUS; AFFERENT PATHWAYS; ALLOSTERIC REGULATION; AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; IONTOPHORESIS; MALE; NEURAL INHIBITION; NEURONS; RATS; RATS, WISTAR; VENTRAL THALAMIC NUCLEI; VIBRISSAE; XANTHENES; XANTHURENATES;

EID: 84872140086     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.03.009     Document Type: Article

References (93)

1. G.K. Aghajanian, and G.J. Marek Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release Brain Res. 825 1999 161 171
2. A. Ahnaou, F.M. Dautzenberg, H. Geys, H. Imogai, A. Gibelin, D. Moechars, T. Steckler, and W.H. Drinkenburg Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture Eur. J. Pharmacol. 603 2009 62 72
3. R. Anwyl Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res. Brain Res. Rev. 29 1999 83 120
4. N. Aoyama, N. Takahashi, S. Saito, N. Maeno, R. Ishihara, X. Ji, H. Miura, M. Ikeda, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, K. Yoshida, N. Iwata, T. Inada, and N. Ozaki Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population Genes Brain Behav. 5 2006 364 368
5. D.A. Baker, A. Madayag, L.V. Kristiansen, J.H. Meador-Woodruff, V. Haroutunian, and I. Raju Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine Neuropsychopharmacology 33 2008 1760 1772
6. G. Battaglia, J.A. Monn, and D.D. Schoepp In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats Neurosci. Lett. 229 1997 161 164
7. M.A. Benneyworth, Z. Xiang, R.L. Smith, E.E. Garcia, P.J. Conn, and E. Sanders-Bush A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis Mol. Pharmacol. 72 2007 477 484
8. K.E. Binns, J.P. Turner, and T.E. Salt Kainate receptor (GluR5)-mediated disinhibition of responses in rat ventrobasal thalamus allows a novel sensory processing mechanism J. Physiol. 551 2003 525 537
9. E.J. Brnardic, M.E. Fraley, R.M. Garbaccio, M.E. Layton, J.M. Sanders, C. Culberson, M.A. Jacobson, B.C. Magliaro, P.H. Hutson, J.A. O'Brien, S.L. Huszar, J.M. Uslaner, K.L. Fillgrove, C. Tang, Y. Kuo, S.M. Sur, and G.D. Hartman 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: hit-to-lead efforts Bioorg. Med. Chem. Lett. 20 2010 3129 3133
10. J. Cartmell, J.A. Monn, and D.D. Schoepp The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-Amphetamine motor behaviors in rats J. Pharmacol. Exp. Ther. 291 1999 161 170
11. J. Cartmell, J.A. Monn, and D.D. Schoepp Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine Psychopharmacology (Berl.) 148 2000 423 429
12. J. Cartmell, J.A. Monn, and D.D. Schoepp The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing Eur. J. Pharmacol. 400 2000 221 224
13. S.Y. Cherlyn, P.S. Woon, J.J. Liu, W.Y. Ong, G.C. Tsai, and K. Sim Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance Neurosci. Biobehav. Rev. 34 2010 958 977
14. J. Cirone, and T.E. Salt Group II and III metabotropic glutamate receptors contribute to different aspects of visual response processing in the rat superior colliculus J. Physiol. 534 2001 169 178
15. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol. 37 1997 205 237
16. C.S. Copeland, S.A. Neale, and T.E. Salt Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus J. Physiol. 590 2012 937 951
17. C. Corti, L. Crepaldi, S. Mion, A.L. Roth, J.H. Xuereb, and F. Ferraguti Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia Biol. Psychiatry 62 2007 747 755
18. C.L. Cox, and S.M. Sherman Glutamate inhibits thalamic reticular neurons J. Neurosci. 19 1999 6694 6699
19. J.W. Crabtree Intrathalamic sensory connections mediated by the thalamic reticular nucleus Cell Mol. Life Sci. 56 1999 683 700
20. M.E. Diamond, M. Armstrong-James, M.J. Budway, and F.F. Ebner Somatic sensory responses in the rostral sector of the posterior group (POm) and in the ventral posterior medial nucleus (VPM) of the rat thalamus: dependence on the barrel field cortex J. Comp. Neurol. 319 1992 66 84
21. S. Erhardt, K. Blennow, C. Nordin, E. Skogh, L.H. Lindstrom, and G. Engberg Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia Neurosci. Lett. 313 2001 96 98
22. Fazio, F.; Molinaro, G.; Iacovelli, L.; Bernabucci, M.; Mauro, G.; Di Menna, L.; Notartomaso, S.; Zappulla, C.; D'Amore, V.; Battaglia, G.; Nicoletti, F.; Bruno, V.; Di Marco, R.; 2011. Xanthurenic Acid as a novel putative agonist of Group II metabotropic glutamate receptors. 7th International Meeting on Metabotropic Receptors, Abstract.
23. F. Fazio, G. Molinaro, L. Iacovelli, M. Bernabucci, G. Mauro, L. Di Menna, S. Notartomaso, C. Zappulla, G. Battaglia, F. Nicoletti, V. Bruno, and R. Di Marco Xanthurenic Acid as a novel putative agonist of Group II metabotropic glutamate receptors Curr. Neuropharmacol. 9 2012 19
24. R. Freedman, A. Olincy, R.G. Ross, M.C. Waldo, K.E. Stevens, L.E. Adler, and S. Leonard The genetics of sensory gating deficits in schizophrenia Curr. Psychiatry Rep. 5 2003 155 161
25. R. Galici, N.G. Echemendia, A.L. Rodriguez, and P.J. Conn A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity J. Pharmacol. Exp. Ther. 315 2005 1181 1187
26. R. Galici, C.K. Jones, K. Hemstapat, Y. Nong, N.G. Echemendia, L.C. Williams, T. de Paulis, and P.J. Conn Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice J. Pharmacol. Exp. Ther. 318 2006 173 185
27. S. Ghose, K.A. Gleason, B.W. Potts, K. Lewis-Amezcua, and C.A. Tamminga Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? Am. J. Psychiatry 166 2009 812 820
28. S. Gobaille, V. Kemmel, D. Brumaru, C. Dugave, D. Aunis, and M. Maitre Xanthurenic acid distribution, transport, accumulation and release in the rat brain J. Neurochem. 105 2008 982 993
29. J. Gonzalez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, J.F. Lopez-Gimenez, M. Zhou, Y. Okawa, L.F. Callado, G. Milligan, J.A. Gingrich, M. Filizola, J.J. Meana, and S.C. Sealfon Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97
30. G. Gu, D.S. Lorrain, H. Wei, R.L. Cole, X. Zhang, L.P. Daggett, H.J. Schaffhauser, L.J. Bristow, and S.M. Lechner Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition Brain Res. 1197 2008 47 62
31. E.A. Hackler, N.E. Byun, C.K. Jones, J.M. Williams, R. Baheza, S. Sengupta, M.D. Grier, M. Avison, P.J. Conn, and J.C. Gore Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation Neuroscience 168 2010 209 218
32. S. Harich, G. Gross, and A. Bespalov Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment Psychopharmacology (Berl.) 192 2007 511 519
33. R.M. Harris, and A.E. Hendrickson Local circuit neurons in the rat ventrobasal thalamus-A GABA immunocytochemical study Neuroscience 21 1987 229 236
34. J.A. Hartings, and D.J. Simons Inhibition suppresses transmission of tonic vibrissa-evoked activity in the rat ventrobasal thalamus J. Neurosci. 20 2000 RC100
35. K. Hemstapat, H. Da Costa, Y. Nong, A.E. Brady, Q. Luo, C.M. Niswender, G.D. Tamagnan, and P.J. Conn A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 322 2007 254 264
36. M.L. Hermes, and L.P. Renaud Post- and presynaptic group II metabotropic glutamate receptors reduce neuronal excitability in rat midline paraventricular thalamic nucleus J. Pharmacol. Exp. Ther. 336 2010 840 849
37. M.P. Johnson, M. Baez, G.E. Jagdmann Jr.; T.C. Britton, T.H. Large, D.O. Callagaro, J.P. Tizzano, J.A. Monn, and D.D. Schoepp Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl) pyrid-3-ylmethylamine J. Med. Chem. 46 2003 3189 3192
38. E.G. Jones The Thalamus 1985 Raven New York
39. J.T. Kantrowitz, and D.C. Javitt Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models Clin. Schizophr. Relat. Psychoses 4 2010 189 200
40. T. Kenakin New concepts in drug discovery: collateral efficacy and permissive antagonism Nat. Rev. Drug Discov. 4 2005 919 927
41. P. Keov, P.M. Sexton, and A. Christopoulos Allosteric modulation of G protein-coupled receptors: a pharmacological perspective Neuropharmacology 60 2011 24 35
42. P. Lavallee, and M. Deschenes Dendroarchitecture and lateral inhibition in thalamic barreloids J. Neurosci. 24 2004 6098 6105
43. K. Leach, R.E. Loiacono, C.C. Felder, D.L. McKinzie, A. Mogg, D.B. Shaw, P.M. Sexton, and A. Christopoulos Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties Neuropsychopharmacology 35 2010 855 869
44. S.M. Lee, M.H. Friedberg, and F.F. Ebner The role of GABA-mediated inhibition in the rat ventral posterior medial thalamus. II. Differential effects of GABAA and GABAB receptor antagonists on responses of VPM neurons J. Neurophysiol. 71 1994 1716 1726
45. X.B. Liu, A. Munoz, and E.G. Jones Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus J. Comp. Neurol. 395 1998 450 465
46. D.S. Lorrain, C.S. Baccei, L.J. Bristow, J.J. Anderson, and M.A. Varney Effects of ketamine and N-methyl-d-Aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Neuroscience 117 2003 697 706
47. D.S. Lorrain, H. Schaffhauser, U.C. Campbell, C.S. Baccei, L.D. Correa, B. Rowe, D.E. Rodriguez, J.J. Anderson, M.A. Varney, A.B. Pinkerton, J.M. Vernier, and L.J. Bristow Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge Neuropsychopharmacology 28 2003 1622 1632
48. G.J. Marek, R.A. Wright, D.D. Schoepp, J.A. Monn, and G.K. Aghajanian Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex J. Pharmacol. Exp. Ther. 292 2000 76 87
49. Mauro, G.; Fazio, F.; Molinaro, G.; Iacovelli, L.; Ngomba, R.T.; Di Menna, L.; Notartomaso, S.; D'Amore, V.; Nasca, C.; Romano, S.; Zappulla, C.; Battaglia, G.; Di Marco, R.; Nicoletti, F.; Bruno, V.; 2010. Xanthurenic acid, as a novel endogenous ligand for metabotropic glutamate receptors. Society for Neuroscience Annual Meeting, Society for Neuroscience, San Diego, CA.
50. C.L. Miller, I.C. Llenos, M. Cwik, J. Walkup, and S. Weis Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder Neurochem. Int. 52 2008 1297 1303
51. C.L. Miller, I.C. Llenos, J.R. Dulay, M.M. Barillo, R.H. Yolken, and S. Weis Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia Neurobiol. Dis. 15 2004 618 629
52. C.L. Miller, I.C. Llenos, J.R. Dulay, and S. Weis Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder Brain Res. 1073-1074 2006 25 37
53. E. Mineff, and J. Valtschanoff Metabotropic glutamate receptors 2 and 3 expressed by astrocytes in rat ventrobasal thalamus Neurosci. Lett. 270 1999 95 98
54. K. Mitsukawa, R. Yamamoto, S. Ofner, J. Nozulak, O. Pescott, S. Lukic, N. Stoehr, C. Mombereau, R. Kuhn, K.H. McAllister, H. van der Putten, J.F. Cryan, and P.J. Flor A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo Proc. Natl. Acad. Sci. U.S.A. 102 2005 18712 18717
55. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
56. M.M. Moran, R. Melendez, D. Baker, P.W. Kalivas, and J.K. Seamans Cystine/glutamate antiporter regulation of vesicular glutamate release Ann. N.Y. Acad. Sci. 1003 2003 445 447
57. M.A. Nicolelis, and J.K. Chapin Spatiotemporal structure of somatosensory responses of many-neuron ensembles in the rat ventral posterior medial nucleus of the thalamus J. Neurosci. 14 1994 3511 3532
58. F. Nicoletti, J. Bockaert, G.L. Collingridge, P.J. Conn, F. Ferraguti, D.D. Schoepp, J.T. Wroblewski, and J.P. Pin Metabotropic glutamate receptors: from the workbench to the bedside Neuropharmacology 60 2011 1017 1041
59. A. Nikiforuk, P. Popik, K.U. Drescher, M.M. van Gaalen, A.L. Relo, M. Mezler, G. Marek, H. Schoemaker, G. Gross, and A. Bespalov Effects of a positive allosteric modulator of mGlu2 receptors LY487379 on cognitive flexibility and impulsive-like responding in rats J. Pharmacol. Exp. Ther. 335 2010 665 673
60. L.K. Nilsson, K.R. Linderholm, G. Engberg, L. Paulson, K. Blennow, L.H. Lindstrom, C. Nordin, A. Karanti, P. Persson, and S. Erhardt Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia Schizophr. Res. 80 2005 315 322
61. C.M. Niswender, and P.J. Conn Metabotropic glutamate receptors: physiology pharmacology and disease Annu. Rev. Pharmacol. Toxicol. 50 2010 295 322
62. P.T. Ohara, and A.R. Lieberman Some aspects of the synaptic circuitry underlying inhibition in the ventrobasal thalamus J. Neurocytol. 22 1993 815 825
63. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, B.V. Andreev, A.S. Avedisova, L.M. Bardenstein, I.Y. Gurovich, M.A. Morozova, S.N. Mosolov, N.G. Neznanov, A.M. Reznik, A.B. Smulevich, V.A. Tochilov, B.G. Johnson, J.A. Monn, and D.D. Schoepp Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat. Med. 13 2007 1102 1107
64. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Co-ordinates 1998 Academic Pres San Diego, CA
65. R.S. Petralia, Y.X. Wang, A.S. Niedzielski, and R.J. Wenthold The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 1996 949 976
66. D. Pinault Dysfunctional thalamus-related networks in schizophrenia Schizophr. Bull. 37 2011 238 243
67. D. Pinault, and M. Deschenes Anatomical evidence for a mechanism of lateral inhibition in the rat thalamus Eur. J. Neurosci. 10 1998 3462 3469
68. O. Poisik, D.V. Raju, M. Verreault, A. Rodriguez, O.A. Abeniyi, P.J. Conn, and Y. Smith Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus Neuropharmacology 49 suppl. 1 2005 57 69
69. H.H.I. Ralston The synaptic organization of the ventrobasal thalamus in the rat, cat and monkey G. Macchi, A. Rustioni, R. Spreafico, Somatosensory Integration in the Thalamus 1983 Elsevier Science Amsterdam 241 250
70. L.M. Rorick-Kehn, B.G. Johnson, K.M. Knitowski, C.R. Salhoff, J.M. Witkin, K.W. Perry, K.I. Griffey, J.P. Tizzano, J.A. Monn, D.L. McKinzie, and D.D. Schoepp In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders Psychopharmacology (Berl.) 193 2007 121 136
71. B.A. Rowe, H. Schaffhauser, S. Morales, L.S. Lubbers, C. Bonnefous, T.M. Kamenecka, J. McQuiston, and L.P. Daggett Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site J. Pharmacol. Exp. Ther. 326 2008 240 251
72. T.E. Salt Mediation of thalamic sensory input by both NMDA receptors and non-NMDA receptors Nature 322 1986 263 265
73. T.E. Salt Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus J. Physiol. 391 1987 499 510
74. T.E. Salt Gamma-Aminobutyric acid and afferent inhibition in the cat and rat ventrobasal thalamus Neuroscience 28 1989 17 26
75. T.E. Salt, and S.A. Eaton Function of non-NMDA receptors and NMDA receptors in synaptic responses to natural somatosensory stimulation in the ventrobasal thalamus Exp. Brain Res. 77 1989 646 652
76. T.E. Salt, and S.A. Eaton Distinct presynaptic metabotropic receptors for L-AP4 and CCG1 on GABAergic terminals: pharmacological evidence using novel alpha-methyl derivative mGluR antagonists, MAP4 and MCCG, in the rat thalamus in vivo Neuroscience 65 1995 5 13
77. T.E. Salt, and S.A. Eaton Modulation of sensory neurone excitatory and inhibitory responses in the ventrobasal thalamus by activation of metabotropic excitatory amino acid receptors Neuropharmacology 34 1995 1043 1051
78. T.E. Salt, and S.A. Eaton Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus Prog. Neurobiol. 48 1996 55 72
79. T.E. Salt, S.A. Eaton, and J.P. Turner Characterization of the metabotropic glutamate receptors (mGluRs) which modulate GABA-mediated inhibition in the ventrobasal thalamus Neurochem. Int. 29 1996 317 322
80. T.E. Salt, and J.P. Turner Modulation of sensory inhibition in the ventrobasal thalamus via activation of group II metabotropic glutamate receptors by 2R,4R-Aminopyrrolidine-2,4-dicarboxylate Exp. Brain Res. 121 1998 181 185
81. Sathyasaikumar, K.V.; Stachowski, E.K.; Wonodi, I.; Roberts, R.C.; Thaker, G.K.; Schwarcz, R.; 2009. Impairment of kynurenine 3-monooxygenase in the frontal cortex of individuals with schizophrenia: association with the eye tracking endophenotype. Society for Neuroscience Annual Meeting. Society for Neuroscience, Chicago, IL.
82. A. Sawa, and S.H. Snyder Schizophrenia: neural mechanisms for novel therapies Mol. Med. 9 2003 3 9
83. H. Schaffhauser, B.A. Rowe, S. Morales, L.E. Chavez-Noriega, R. Yin, C. Jachec, S.P. Rao, G. Bain, A.B. Pinkerton, J.M. Vernier, L.J. Bristow, M.A. Varney, and L.P. Daggett Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2 Mol. Pharmacol. 64 2003 798 810
84. D.D. Schoepp, and G.J. Marek Preclinical pharmacology of mGluR2/3 receptor agonists: novel agents for schizophrenia? CNS Neurol. Disord. Drug Targets 1 2002 215 225
85. R. Schwarcz, A. Rassoulpour, H.Q. Wu, D. Medoff, C.A. Tamminga, and R.C. Roberts Increased cortical kynurenate content in schizophrenia Biol. Psychiatry 50 2001 521 530
86. Schwarcz, R.; Sathyasaikumar, K.V.; Stachowski, E.K.; Wonodi, I.; Roberts, R.C.; Thaker, G.K.; 2009. Impaired cortical kynurenine pathway metabolism in schizophrenia: focus on kynurenine 3-monooxygenase. The 12th International Congress on Schizophrenia Research, San Diego, CA.
87. A. Shosaku, Y. Kayama, I. Sumitomo, M. Sugitani, and K. Iwama Analysis of recurrent inhibitory circuit in rat thalamus: neurophysiology of the thalamic reticular nucleus Prog. Neurobiol. 32 1989 77 102
88. Y. Tamaru, S. Nomura, N. Mizuno, and R. Shigemoto Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites Neuroscience 106 2001 481 503
89. J.P. Turner, and T.E. Salt Characterization of sensory and corticothalamic excitatory inputs to rat thalamocortical neurones in vitro J. Physiol. 510 Pt 3 1998 829 843
90. J.P. Turner, and T.E. Salt Group II and III metabotropic glutamate receptors and the control of the nucleus reticularis thalami input to rat thalamocortical neurones in vitro Neuroscience 122 2003 459 469
91. I. Wonodi, and R. Schwarcz Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia Schizophr. Bull. 36 2010 211 218
92. R.A. Wright, M.B. Arnold, W.J. Wheeler, P.L. Ornstein, and D.D. Schoepp [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain J. Pharmacol. Exp. Ther. 298 2001 453 460
93. Z.X. Xi, D.A. Baker, H. Shen, D.S. Carson, and P.W. Kalivas Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens J. Pharmacol. Exp. Ther. 300 2002 162 171